Cargando…

Refractory Primary Vitreoretinal Lymphoma Involving the Spinal Cord with a Temporary Complete Response to Tirabrutinib

Many patients with primary vitreoretinal lymphoma (PVRL) exhibit central nervous system (CNS) involvement either at the diagnosis or during follow-up. The prognosis in the patients of PVRL with relapsed or refractory CNS remains extremely poor. We herein report a patient with refractory PVRL who had...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iizuka-Honma, Hiroko, Takizawa, Haruko, Mitsumori, Toru, Okura, Hidehiro, Ishii, Hisato, Noguchi, Masaaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970806/ https://www.ncbi.nlm.nih.gov/pubmed/35793963 http://dx.doi.org/10.2169/internalmedicine.9591-22

Ejemplares similares

Development of rapidly fatal TAFRO syndrome-like features in a patient with essential thrombocythemia
por: Iizuka-Honma, Hiroko, et al.
Publicado: (2023)

Possible New Histological Prognostic Index for Large B-Cell Lymphoma
por: Nitta, Hideaki, et al.
Publicado: (2023)

Histological verification of the treatment effect of tirabrutinib for relapsed/refractory primary central nervous system lymphoma
por: Okita, Yoshiko, et al.
Publicado: (2021)

ML-21 Tirabrutinib monotherapy for relapsed/refractory primary central nervous system lymphoma
por: Kobayashi, Keiichi, et al.
Publicado: (2020)

ML-11 Tirabrutinib treatment for recurrent or refractory PCNSL
por: Ohka, Fumiharu, et al.
Publicado: (2021)

Role of TGF-beta1 and TNF-alpha1 produced by neoplastic cells in the pathogenesis of fibrosis in patients with hematologic neoplasms
por: Takizawa, Haruko, et al.
Publicado: (2023)

Primary Vitreoretinal Lymphoma Masquerading as Refractory Retinitis
por: Zloto, Ofira, et al.
Publicado: (2015)

Vitreoretinal Lymphoma
por: Sobolewska, Bianka, et al.
Publicado: (2021)

ML-9 TREATMENT OUTCOMES OF TIRABRUTINIB FOR RELAPSED AND REFRACTORY PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA IN A SINGLE INSTITUTE
por: Ohka, Fumiharu, et al.
Publicado: (2022)

Relapsed refractory nodal peripheral T-cell lymphoma with follicular helper T-cell phenotype was initially resistant to pralatrexate and confirmed to be unresponsive to subsequent forodesine, but responded to re-instituted pralatrexate
por: Sekiguchi, Yasunobu, et al.
Publicado: (2020)

Primary vitreoretinal lymphoma
por: Mulay, Kaustubh, et al.
Publicado: (2015)

Primary vitreoretinal lymphoma
por: Kalogeropoulos, Dimitrios, et al.
Publicado: (2019)

ML-10 Tirabrutinib, a second-generation BTK inhibitor in relapsed and refractory primary CNS lymphoma: A single institute study
por: Mishima, Kazuhiko, et al.
Publicado: (2021)

Karnofsky Performance Status and quality of life in patients with relapsed or refractory primary CNS lymphoma from a phase I/II study of tirabrutinib
por: Arakawa, Yoshiki, et al.
Publicado: (2023)

Bing-Neel Syndrome Successfully Treated with Tirabrutinib
por: Oyama, Takashi, et al.
Publicado: (2022)

Phase I/II study of tirabrutinib, a second-generation Bruton’s tyrosine kinase inhibitor, in relapsed/refractory primary central nervous system lymphoma
por: Narita, Yoshitaka, et al.
Publicado: (2020)

Waldenstrom Macroglobulinemia/Lymphoplasmacytic Lymphoma Associated with Nephrotic Syndrome during Hemodialysis, Treated Successfully with Tirabrutinib
por: Sekiguchi, Yasunobu, et al.
Publicado: (2022)

Secondary vitreoretinal lymphoma with spontaneous regression
por: Kongwattananon, Wijak, et al.
Publicado: (2022)

Rapidly Progressive Bilateral Vitreoretinal Lymphoma
por: Fong, Joseph W, et al.
Publicado: (2022)

ML-05 One-year follow-up data of phase I/II study of tirabrutinib in patients with relapsed or refractory primary central nervous system lymphoma
por: Mishima, Kazuhiko, et al.
Publicado: (2020)

Two‐year outcomes of tirabrutinib monotherapy in Waldenström’s macroglobulinemia
por: Sekiguchi, Naohiro, et al.
Publicado: (2022)

Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma
por: Morschhauser, Franck, et al.
Publicado: (2020)

Primary Skeletal Muscle Peripheral T-cell Lymphoma: An Autopsy Case Report and Review of the Literature
por: Iizuka, Hiroko, et al.
Publicado: (2021)

Phase I study of tirabrutinib (ONO‐4059/GS‐4059) in patients with relapsed or refractory B‐cell malignancies in Japan
por: Munakata, Wataru, et al.
Publicado: (2019)

Molecular Biomarkers for the Diagnosis of Primary Vitreoretinal Lymphoma
por: Wang, Yujuan, et al.
Publicado: (2011)

An unusual case report of primary vitreoretinal lymphoma
por: Tan, Shi Zhuan, et al.
Publicado: (2018)

Gene expression profiling of primary vitreoretinal lymphoma
por: Arai, Ayako, et al.
Publicado: (2020)

The molecular hallmarks of primary and secondary vitreoretinal lymphoma
por: Bonzheim, Irina, et al.
Publicado: (2022)

Multimodal diagnostic imaging in primary vitreoretinal lymphoma
por: Xu, Lucy T., et al.
Publicado: (2022)

Anti-myelin-associated-glycoprotein neuropathy successfully treated with tirabrutinib
por: Yasuda, Hajime, et al.
Publicado: (2022)

The Impact of Tirabrutinib Monotherapy for Bing-Neel Syndrome in Waldenström's Macroglobulinemia
por: Sekiguchi, Naohiro
Publicado: (2022)

BTK mutations in patients with chronic lymphocytic leukemia receiving tirabrutinib
por: Jackson, Ross A., et al.
Publicado: (2023)

Methotrexate-associated Hodgkin Lymphoma in a Patient with Rheumatoid Arthritis Successfully Treated with Brentuximab Vedotin in Combination with Doxorubicin, Vinblastine, and Dacarbazine (BV+AVD)
por: Sekiguchi, Yasunobu, et al.
Publicado: (2020)

Vitreoretinal lymphoma followed by systemic diffuse large B cell lymphoma
por: Fan, Kenneth C., et al.
Publicado: (2019)

ML-16 First clinical experience of administration of Tirabrutinib for the patients with newly diagnosed primary central nervous system lymphoma
por: Onodera, Sho, et al.
Publicado: (2021)

Subretinal pigment epithelial infiltrates in primary vitreoretinal lymphoma
por: Vasconcelos-Santos, Daniel Vítor, et al.
Publicado: (2011)

Diagnostic efficacy of cell block method for vitreoretinal lymphoma
por: Kase, Satoru, et al.
Publicado: (2016)

The diagnosis and treatment of primary vitreoretinal lymphoma: a review
por: Pulido, Jose S., et al.
Publicado: (2018)

Primary vitreoretinal lymphoma: prevalence, impact, and management challenges
por: Venkatesh, Ramesh, et al.
Publicado: (2019)

Recent progress in the diagnosis and treatment of primary vitreoretinal lymphoma
por: Zhou, Min, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4ccseibfv4ppdvr7dd8vbks5b2